Skip to main content
logo
VitaNova Life Sciences Corporation (VNOV)
OTCMKTS · Delayed Price · Currency is USD
2.380
0.00 (0.00%)
Oct 8, 2026, 4:00 PM EDT

VitaNova Life Sciences Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Revenue
3.243.032.660.570.040.12
Revenue Growth
22.04%13.65%366.47%1401.83%-68.33%-
Cost of Revenue
2.372.111.090.19--
Gross Profit
0.870.911.580.380.040.12
Selling, General & Admin
0.960.910.370.170.060.13
Operating Expenses
0.960.910.370.170.060.13
Operating Income
-0.0901.210.21-0.02-0.01
Interest Expense
---0---
Other Non Operating Income (Expenses)
0000--
EBT Excluding Unusual Items
-0.080.011.20.21-0.02-0.01
Other Unusual Items
-----0.15
Pretax Income
-0.080.011.20.21-0.020.14
Income Tax Expense
0.030.040.350.06--
Earnings From Continuing Operations
-0.11-0.040.850.14-0.020.14
Net Income
-0.11-0.040.850.14-0.020.14
Net Income to Common
-0.11-0.040.850.14-0.020.14
Net Income Growth
--503.94%---
Shares Outstanding (Basic)
888422
Shares Outstanding (Diluted)
888422
Shares Change
--135.00%81.28%--
EPS (Basic)
-0.01-0.000.100.04-0.010.07
EPS (Diluted)
-0.01-0.000.100.04-0.010.06
EPS Growth
--157.00%---

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
0.560.810.19-0.38-0.020
Free Cash Flow Per Share
0.070.100.02-0.11-0.010.00
Gross Margin
26.90%30.10%59.19%66.19%100.00%100.00%
Operating Margin
-2.66%0.12%45.39%36.03%-63.75%-11.14%
Profit Margin
-3.52%-1.23%31.96%24.68%-63.75%116.40%
Free Cash Flow Margin
17.19%26.92%7.24%-65.86%-48.35%3.38%
EBIT
-0.0901.210.21-0.02-0.01
EBIT Margin
-2.66%0.12%45.39%36.03%-63.75%-11.14%
Effective Tax Rate
-666.84%29.36%31.53%--